Duoneb and Chronic obstructive pulmonary disease - a phase IV clinical study of FDA data
Summary:
Chronic obstructive pulmonary disease is reported as a side effect among people who take Duoneb (albuterol sulfate; ipratropium bromide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Spiriva, and have Pain.
The phase IV clinical study analyzes which people have Chronic obstructive pulmonary disease when taking Duoneb. It is created by eHealthMe based on reports of 8,008 people who have side effects when taking Duoneb from the FDA, and is updated regularly.
What is Duoneb?
Duoneb has active ingredients of albuterol sulfate; ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 8,093 Duoneb users. Check the latest studies of Duoneb.
What is Chronic obstructive pulmonary disease?
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe) is found to be associated with 1,807 drugs and 2,206 conditions by eHealthMe. Check the latest studies of Chronic obstructive pulmonary disease.
8,008 people reported to have side effects when taking Duoneb.
Among them, 681 people (8.5%) have Chronic obstructive pulmonary disease.
Among these 681 people:
How long have people been on Duoneb when they have Chronic obstructive pulmonary disease? *
What is the gender of people who have Chronic obstructive pulmonary disease when taking Duoneb? *
What is the age of people who have Chronic obstructive pulmonary disease when taking Duoneb? *
What are other drugs people take besides Duoneb? *
What are other side effects people have besides Chronic obstructive pulmonary disease? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Duoneb and have Chronic obstructive pulmonary disease?
- Check whether Chronic obstructive pulmonary disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Duoneb:
- Duoneb (8,093 reports)
Chronic obstructive pulmonary disease treatments and more:
- Chronic obstructive pulmonary disease (198,253 reports)
How severe was Chronic obstructive pulmonary disease and when was it recovered:
Expand to all the drugs that have ingredients of albuterol sulfate; ipratropium bromide:
- Chronic obstructive pulmonary disease and drugs with ingredients of albuterol sulfate; ipratropium bromide (2,997 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Duoneb:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Chronic obstructive pulmonary disease:
- Chronic obstructive pulmonary disease (1,807 drugs)
Browse all the conditions that are associated with Chronic obstructive pulmonary disease:
- Chronic obstructive pulmonary disease (2,206 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on albuterol sulfate; ipratropium bromide (the active ingredients of Duoneb) and Duoneb (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Abdominal Discomfort and Chronic Obstructive Pulmonary Disease - 7 seconds ago
- Could Carbidopa cause Restless Leg Syndrome? - 30 seconds ago
- Could Sandostatin cause Mucous Stools? - 34 seconds ago
- Drug interactions of Bendamustine and Paclitaxel - 38 seconds ago
- Could Soriatane cause Abdominal Discomfort? - 40 seconds ago
- Could Sulfasalazine cause Tongue Ulceration? - 50 seconds ago
- Could Ondansetron Hydrochloride cause Herpes Zoster? - 51 seconds ago
- Could Nardil cause Taste - Impaired? - 57 seconds ago
- Flatulence and Ulcerative Colitis - a minute ago
- Could Tofacitinib cause Nasopharyngitis? - a minute ago